Open-label, Extension Study of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in Patients With Schizophrenia
Public ClinicalTrials.gov record NCT01683058. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A 26-week, Multicenter, Open-label, Extension Study of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in Patients With Schizophrenia
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The phase 3 Trial 31-12-291 is part of the aripiprazole IM depot clinical development program and has been designed to demonstrate the efficacy and safety of aripiprazole IM depot for the treatment of adults experiencing an acute relapse of schizophrenia. Subjects receive treatment during a 12-week double-blind acute treatment phase. The current trial (31-12-297) will allow the subjects who complete Trial 291 to enter this open label trial at the investigator's discretion, where additional safety and tolerability data will be collected.
Study identification
- NCT ID
- NCT01683058
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 74 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 66 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 2013 (Type not available)
- Primary completion
- Feb 2014 (Actual)
- Completion
- Feb 2014 (Actual)
- Last update posted
- Mar 31, 2015
2013 – 2014
United States locations
- U.S. sites
- 35
- U.S. states
- 14
- U.S. cities
- 29
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Little Rock | Arkansas | 72201 | — |
| Not listed | Springdale | Arkansas | 72764 | — |
| Not listed | Carson | California | 90746 | — |
| Not listed | Escondido | California | 92025 | — |
| Not listed | Garden Grove | California | 92845 | — |
| Not listed | Long Beach | California | 90813 | — |
| Not listed | National City | California | 91950 | — |
| Not listed | Oakland | California | 94612 | — |
| Not listed | Pico Rivera | California | 90660 | — |
| Not listed | San Diego | California | 92102 | — |
| Not listed | San Diego | California | 92123 | — |
| Not listed | Santa Ana | California | 92701 | — |
| Not listed | Sherman Oaks | California | 91403 | — |
| Not listed | Washington D.C. | District of Columbia | 20016 | — |
| Not listed | Fort Lauderdale | Florida | 33301 | — |
| Not listed | Fort Lauderdale | Florida | 33308 | — |
| Not listed | Fort Lauderdale | Florida | 33334 | — |
| Not listed | Kissimmee | Florida | 34741 | — |
| Not listed | North Miami | Florida | 33162 | — |
| Not listed | Orlando | Florida | 32810 | — |
| Not listed | Atlanta | Georgia | 30308 | — |
| Not listed | Hoffman Estates | Illinois | 60169 | — |
| Not listed | Lake Charles | Louisiana | 70629 | — |
| Not listed | Flowood | Mississippi | 39232 | — |
| Not listed | St Louis | Missouri | 63118 | — |
| Not listed | St Louis | Missouri | 63128 | — |
| Not listed | Marlton | New Jersey | 08053 | — |
| Not listed | Holliswood | New York | 11423 | — |
| Not listed | Dayton | Ohio | 45417 | — |
| Not listed | Philadelphia | Pennsylvania | 19139 | — |
| Not listed | Austin | Texas | 78731 | — |
| Not listed | Austin | Texas | 78754 | — |
| Not listed | Dallas | Texas | 75231 | — |
| Not listed | Dallas | Texas | 75243 | — |
| Not listed | Houston | Texas | 77007 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01683058, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 31, 2015 · Synced Oct 31, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01683058 live on ClinicalTrials.gov.